Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
13 May 2024 Job Information Organisation/Company KU Leuven Research Field Medical sciences » Medicine Researcher Profile First Stage Researcher (R1) Country Belgium Application Deadline 28 Jun 2024
-
11 May 2024 Job Information Organisation/Company KU Leuven Research Field Medical sciences » Other Researcher Profile Recognised Researcher (R2) Country Belgium Application Deadline 3 Jun 2024 - 00
-
to design genes and cells for biotechnological applications. Who we are The lab for Systems Biology of Kevin Verstrepen is a research team at the VIB-KU Leuven Center for Microbiology. Our team focuses
-
to design genes and cells for biotechnological applications. Who we are The lab for Systems Biology of Kevin Verstrepen is a research team at the VIB-KU Leuven Center for Microbiology. Our team focuses
-
KU Leuven/BioTeC+ (Chemical & Biochemical Process Technology & Control) | Belgium | about 2 months ago
through the online application tool: https://www.kuleuven.be/personeel/jobsite/jobs/60323694?lang=enHiring organisation and offer posting contact details:Organisation: KU Leuven/BioTeC+ (Chemical &
-
4 May 2024 Job Information Organisation/Company KU Leuven Research Field Biological sciences » Other Researcher Profile Recognised Researcher (R2) Country Belgium Application Deadline 30 May 2024
-
universities in Flanders – Ghent University, KU Leuven, University of Antwerp, Vrije Universiteit Brussel and Hasselt University. VIB is an independent research institute of the government, with about 1900
-
with institutes across Europe, including the Danish Technical University, Chalmers University, KU Leuven, and industrial partner OCAS, a trademark of ArcelorMittal. Your responsibilities include
-
at the BioTeC+ group of KU Leuven/Campus Gent (Belgium). KU Leuven/BioTeC+ is a multidisciplinary team at the interface of in silico systems biology and in vitro experimental predictive microbiology
-
About us The Laboratory of Proteolytic Mechanisms Mediating Neurodegeneration, which is part of the VIB-KU Leuven Center for Brain & Disease Research, is committed to advancing scientific knowledge